Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
Authors
Keywords
Immune checkpoint inhibitors, Myasthenia gravis, Immune-related adverse events, Pembrolizumab, Nivolumab, Ipilimumab, PD-1, CTLA-4, Autoimmunity
Journal
EUROPEAN JOURNAL OF CANCER
Volume 82, Issue -, Pages 128-136
Publisher
Elsevier BV
Online
2017-06-28
DOI
10.1016/j.ejca.2017.05.041

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.